Transfection Technologies Market
Transfection Technologies Market By Application (Protein Production, Therapeutic Delivery, Bio-medical Research), By Method (Reagent-based Method, Instrument-based Method), By Technology, By End User & By Region - Global Market Insights 2023 to 2033
Analysis of Transfection Technologies Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Transfection Technologies Market Outlook (2023 to 2033)
Worldwide transfection technology sales are valued at around US$ 1.10 billion in 2023. The global transfection technologies market is projected to register a CAGR of 7.5% and top a valuation of US$ 2.27 billion by the end of 2033.
Global demand for therapeutic delivery systems is expected to increase at a CAGR of 8% during the next 10 years. The technique of providing a pharmaceutical substance to have a therapeutic effect on people or animals is known as drug delivery or therapeutic delivery.
The importance of nasal and pulmonary medication delivery channels is increasing for the treatment of human diseases. These delivery methods, particularly for peptide and protein therapies, provide intriguing substitutes for parenteral drug administration. For this reason, many medication delivery devices have been developed and are being further researched. These include cyclodextrins, microspheres, gels, prodrugs, liposomes, and proliposomes, among others. Thus, their simple way of application is boosting sales growth.
The biotechnological method for creating a particular protein is known as protein production. It is often accomplished by altering an organism's gene expression to get it to express a recombinant gene in huge quantities. This involves the conversion of the recombinant DNA into messenger RNA (mRNA), translation of the mRNA into polypeptide chains, and eventual folding and targeting of the polypeptide chains into functional proteins at particular subcellular or extracellular sites. Systems for producing proteins, commonly referred to as expression systems, are employed in the biotechnology, medical, and life sciences fields.
Nucleic acids are introduced into eukaryotic cells through the transfection process using nonviral techniques. Gene transfection technologies make it possible to analyse how genes work and how proteins are expressed in cells using a variety of chemical or physical transfection techniques.
The applications for transfection have significantly increased with the invention of reporter gene systems and selection techniques for the steady maintenance and expression of transfected DNA. Transfection technology is segmented into physical-based transfection, chemical-based transfection, and viral-vector-based transfection. Furthermore, the transfection methods are classified into reagent-based methods, instrument-based methods, and virus-based methods.
The outlook for transfection technologies is incredibly appealing since these technologies have a wide range of uses in discovering precise biomarkers by understanding the molecular pathways of diseases, and these biomarkers can be helpful in the diagnosis of chronic diseases such as cancer.
The most significant factors expected to propel the growth of the transfection technologies market during the forecast period are broad-reaching applications in protein production and vaccine development, and proliferation in the prevalence of cancer and other chronic illnesses as the geriatric population is on an abrupt upsurge.
| Report Attributes | Details |
|---|---|
| Market Size (2023E) | US$ 1.10 Billion |
| Forecasted Market Value (2033F) | US$ 2.27 Billion |
| Global Market Growth Rate (2023 to 2033) | 7.5% CAGR |
| China Market Growth Rate (2023 to 2033) | 7% CAGR |
| Japan Market Growth Rate (2023 to 2033) | 6.5% CAGR |
| Germany Market Growth Rate (2023 to 2033) | 6% CAGR |
| Canada Market Growth Rate (2023 to 2033) | 6.5% CAGR |
| Key Companies Profiled | Bio-Rad Laboratories, Inc.; F. Hoffmann-La Roche AG; Life Technologies Corporation; Lonza Group AG; MilliporeSigma; PolyPlus Battery Company (PPBC); Promega Corporation; Qiagen NV; SignaGen Laboratories; Thermo Fisher Scientific, Inc. |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
What Opportunities Await Providers of Transfection Technologies?
“Rising Cases of Chronic Disorders & Viral Infections”
The prevalence of chronic disorders and viral infections are rising across the globe and are responsible for the higher rate of mortality and hospitalizations.
- According to the Centers for Disease Control and Prevention, six out of ten Americans live with at least one chronic illness, such as diabetes, cancer, heart disease, or stroke. These and other chronic illnesses are the main contributors to health care costs as well as the major causes of death and disability in the United States.
According to a recently updated report by WHO,
- Roughly 10 million deaths, or nearly one in six deaths, were caused by cancer in 2020, which makes it the leading cause of death globally.
- Breast, colon, rectum, lung, and prostate cancers are the most common types of cancer.
- In low- and lower-middle-income nations, cancer-causing infections including the human papillomavirus (HPV) and hepatitis are thought to be the cause of 30% of cancer cases.
- At the end of 2021, the WHO estimated that 38.4 million individuals worldwide were HIV positive. Globally, 0.7% of adults between the ages of 15 and 49 are believed to have HIV.
Thus, increasing cases of HIV, boosts its treatment demand, fueling the market growth. As a result, the demand for transfection technologies is rising due to such ongoing trends.
“New Drug Development Prospects Increasing by Focusing on Epigenetic Biomarkers”
Genetic biomarkers commanded a substantial market share due to their widespread use, high reliance rate, and simplicity of analysis. More than 85% of tumours can now be identified with the help of genetic and proteomic biomarkers.
In the field of cancer diagnostics, epigenetics has received significant recognition. To create biomarkers and cancer-targeting medications, numerous players are performing in-depth studies to examine significant epigenetic alterations connected to cancer. Sales growth of the transfection technologies market is anticipated to be fuelled throughout the projected period due to the increasing pharmaceutical companies' cooperation in the development of novel medications that target epigenetic biomarkers.
“Increasing Funding for R&D as Infectious Diseases are Gripping the World”
Key market players in the transfection technologies market are strongly focusing on advancing the technologies and eliminating any present drawbacks. This is attributed to the fact that the prevalence of contagious diseases is rising rapidly across the world.
- As an example, Thermo Fisher Scientific, a significant player in the market for transfection technologies, increased its research spending by more than $150 million in 2020, allocating around $1,181 million to R&D. The numbers are expected to drive the market forward as pharmaceutical companies' profits are likely to climb as a result of the recent COVID-19 pandemic.
Which Aspects Should Manufacturers of Transfection Technologies Focus On?
“Exorbitant Equipment Costs and Complications with Transfection Techniques”
The market may face difficulties because the transfection procedure requires expensive gear. Although chemical transfection techniques are somewhat less expensive, they are also more error-prone.
Additionally, the use of substances such as calcium phosphate can negatively impact how cells function. The amount of total DNA needed in calcium phosphate transfection is typically 10–50g in 450 litres of sterile water and 50 litres of 2.5 M CaCl2 per 10-cm plate, however, this amount varies greatly amongst plasmid preparations, as well as with various cells and conditions.
Due to their bigger holes and ion imbalance, techniques such as electroporation and microinjection are seen as dangerous since they might mutilate cells while penetrating the cellular membrane. This is expected to impede the sales of transfection technologies.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Country-wise Analysis
Why is North America the Most Profitable Market for Transfection Technologies?
“Substantial Existence of Leading Manufacturers”
The global market is currently dominated by North America, due to the factors such as the rising incidence of infectious diseases, which necessitate the use of antibiotics, and the expanding use of cell-based products, which necessitate the use of transfection techniques to treat chronic illnesses such as tuberculosis, cancer, and cardiovascular disorders. The United States and Canada both are the largest users of transfection technologies and the presence of key market players supports sales growth.
- In January 2022, Cellino Biotech, an independent manufacturer of cell treatment products, raised US$ 80 million in a Series A investment transaction. To increase the availability of stem cell-based treatments, Cellino intends to construct the first independent human cell foundry by 2025.
How is Demand for Transfection Technologies Progressing in Asia Pacific?
“Presence of Target Patient Pool and Growing Spending on Healthcare”
India, Japan, China, and South Korea are the leading marketplaces in the Asia Pacific region. India is rapidly developing in the genome sequencing sector.
Growing healthcare spending in Asia Pacific is anticipated to create a favourable environment for established international manufacturers wanting to grow their transfection technologies business. This region also has a growing patient pool with consequent untapped market potential. Additionally, the governments in the region are actively involved in encouraging the use of cell and gene therapies, which supports sales growth.
- For instance, in November 2019, a leading symposium on cell and gene therapy in the Asia Pacific convened a collaborative session to examine the CAR-T industry's prospects in this region.
Why are Suppliers of Transfection Technologies Attracted to European Countries?
“Rapid Developments in Gene & Cell-based Therapies”
The best market for producing items for cell and gene therapy is in Europe. More than 238 firms involved in regenerative medicine are based in Europe.
Nearly a quarter of the therapeutic developers for regenerative medicine come from Europe. Thus, rapid developments in cell and gene therapies are boosting the demand for transfection systems in European countries such as the U.K., Germany, and Italy.
Category-wise Analysis
What Makes the Reagent-based Method Widely Popular?
“Fewer Complications & Higher Affordability”
High gene transfer efficiency, low cytotoxicity, and versatility are all features of the reagents for transfection. Additionally, In-vivo transfection for use in gene therapy applications may utilize this reagent-based method. Reagent-based transfection technologies are also expanding significantly as a result of their affordability and fewer complications in transfection procedures.
- For instance, Helix-IN, a revolutionary, patented Cationic Hydroxylated Amphiphilic Multi-block Polymer developed by OZ Biosciences, revolutionised Polyfection (CHAMP Technology). This brand-new bi-functional copolymer is biodegradable, pH-responsive, ionizable, and biocompatible. As a result, the market is being driven by the increased reagent adoption that results from the availability of products.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Competitive Landscape
Some of the key players in the transfection technologies market are Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, Life Technologies Corporation, Lonza Group AG, MilliporeSigma; PolyPlus Battery Company (PPBC), Promega Corporation, Qiagen NV, SignaGen Laboratories, and Thermo Fisher Scientific, Inc.
- Easy introduction of DNA, RNA, siRNA, or oligonucleotides into eukaryotic cells can be accomplished quickly, simply, and repeatedly via cationic lipid transfection technologies. It permits the highly effective transfection of various cell types, such as adherent, suspension, insect, and primary cultures. Thermo Fisher Scientific, Inc. has a wider portfolio range of cationic-lipid transfection reagents.
- February 3, 2022: To increase their proficiency in the design and production of unique DNA vectors, Polypus, a supplier of transfection reagents, bought e-Zyvec, a company based in France.
- For instance, in March 2019, Lonza introduced CellBio Services, a broad spectrum of distinctive services tailored to the needs of research applications. These include cell-line expansion, transfection, and cell banking services.
Key Segments of Transfection Technologies Industry Research
-
By Application:
- Protein Production
- Therapeutic Delivery
- Biotherapeutics
- Electro-chemotherapy and Electro-immunotherapy
- Bio-medical Research
- Cancer Research
- Transgenic Models
- Gene and Protein Expression Studies
- Cell-based Microarrays for Drug Discovery and Development
-
By Method:
- Reagent-based Method
- Lipid Mediated Transfection (Lipofection)
- Calcium Phosphate
- DEAE-dextran
- Catonic Polymers
- Activated Dendrimers
- Magnetic Beads
- Instrument-based Method
- Electroporation
- Microinjection
- Laserfection
- Biolistic technology
- Virus-based Method
- Reagent-based Method
-
By Technology:
- Physical Transfection
- Biochemical-based Transfection
- Viral-vector-based Transfection
-
By End User:
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations
- Academic & Research Institutes
- Hospitals
-
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- MEA
Table of Content
- 1. Executive Summary
- 2. Market Overview
- 4. Market Background
- 5. Global Market Pricing Analysis
- 6. Global Market Analysis (2018 to 2022) and Forecast (2023 to 2033)
- 7. Global Market Analysis (2018 to 2022) and Forecast (2023 to 2033), by Application
- 7.1. Protein Production
- 7.2. Therapeutic Delivery
- 7.3. Bio-medical Research
- 8. Global Market Analysis (2018 to 2022) and Forecast (2023 to 2033), by Method
- 8.1. Reagent-based Method
- 8.2. Instrument-based Method
- 8.3. Virus-based Method
- 9. Global Market Analysis (2018 to 2022) and Forecast (2023 to 2033), by Technology
- 9.1. Physical Transfection
- 9.2. Biochemical-based Transfection
- 9.3. Viral-vector-based Transfection
- 10. Global Market Analysis (2018 to 2022) and Forecast (2023 to 2033), by End User
- 10.1. Pharmaceutical & Biotechnology Companies
- 10.2. Contract Research Organizations
- 10.3. Academic & Research Institutes
- 10.4. Hospitals
- 11. Global Market Analysis (2018 to 2022) and Forecast (2023 to 2033), by Region
- 11.1. North America
- 11.2. Europe
- 11.3. East Asia
- 11.4. South Asia
- 11.5. Latin America
- 11.6. Middle East & Africa (MEA)
- 11.7. Oceania
- 12. North America Market Analysis and Forecast
- 13. Europe Market Analysis and Forecast
- 14. East Asia Market Analysis and Forecast
- 15. South Asia Market Analysis and Forecast
- 16. Latin America Market Analysis and Forecast
- 17. Middle East & Africa Market Analysis and Forecast
- 18. Oceania Market Analysis and Forecast
- 19. Global Market Analysis Key Countries
- 20. Competition Landscape
- 21. Competition Analysis
- 21.1. Bio-Rad Laboratories, Inc.
- 21.2. F. Hoffmann-La Roche AG
- 21.3. Life Technologies Corporation
- 21.4. Lonza Group AG
- 21.5. MilliporeSigma
- 21.6. PolyPlus Battery Company (PPBC)
- 21.7. Promega Corporation
- 21.8. Qiagen NV
- 21.9. SignaGen Laboratories
- 21.10. Thermo Fisher Scientific, Inc.
- 22. Appendix
- 23. Definitions of Analytical Frameworks
- 24. Sources and References
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Volume (Units), by Application, 2018 to 2033
Table 02: Global Market Value (US$ Mn), by Application, 2018 to 2033
Table 03: Global Market Volume (Units), by Method, 2018 to 2033
Table 04: Global Market Value (US$ Mn), by Method, 2018 to 2033
Table 05: Global Market Volume (Units), by Technology, 2018 to 2033
Table 06: Global Market Value (US$ Mn), by Technology, 2018 to 2033
Table 07: Global Market Volume (Units), by End User, 2018 to 2033
Table 08: Global Market Value (US$ Mn), by End User, 2018 to 2033
Table 09: Global Market Volume (Units), by Region, 2018 to 2033
Table 10: Global Market Value (US$ Mn), by Region, 2018 to 2033
Table 11: North America Market Volume (Units), by Application, 2018 to 2033
Table 12: North America Market Value (US$ Mn), by Application, 2018 to 2033
Table 13: North America Market Volume (Units), by Method, 2018 to 2033
Table 14: North America Market Value (US$ Mn), by Method, 2018 to 2033
Table 15: North America Market Volume (Units), by Technology, 2018 to 2033
Table 16: North America Market Value (US$ Mn), by Technology, 2018 to 2033
Table 17: North America Market Volume (Units), by End User, 2018 to 2033
Table 18: North America Market Value (US$ Mn), by End User, 2018 to 2033
Table 19: North America Market Volume (Units), by Country, 2018 to 2033
Table 20: North America Market Value (US$ Mn), by Country, 2018 to 2033
Table 21: Europe Market Volume (Units), by Application, 2018 to 2033
Table 22: Europe Market Value (US$ Mn), by Application, 2018 to 2033
Table 23: Europe Market Volume (Units), by Method, 2018 to 2033
Table 24: Europe Market Value (US$ Mn), by Method, 2018 to 2033
Table 25: Europe Market Volume (Units), by Technology, 2018 to 2033
Table 26: Europe Market Value (US$ Mn), by Technology, 2018 to 2033
Table 27: Europe Market Volume (Units), by End User, 2018 to 2033
Table 28: Europe Market Value (US$ Mn), by End User, 2018 to 2033
Table 29: Europe Market Volume (Units), by Country, 2018 to 2033
Table 30: Europe Market Value (US$ Mn), by Country, 2018 to 2033
Table 31: East Asia Market Volume (Units), by Application, 2018 to 2033
Table 32: East Asia Market Value (US$ Mn), by Application, 2018 to 2033
Table 33: East Asia Market Volume (Units), by Method, 2018 to 2033
Table 34: East Asia Market Value (US$ Mn), by Method, 2018 to 2033
Table 35: East Asia Market Volume (Units), by Technology, 2018 to 2033
Table 36: East Asia Market Value (US$ Mn), by Technology, 2018 to 2033
Table 37: East Asia Market Volume (Units), by End User, 2018 to 2033
Table 38: East Asia Market Value (US$ Mn), by End User, 2018 to 2033
Table 39: East Asia Market Volume (Units), by Country, 2018 to 2033
Table 40: East Asia Market Value (US$ Mn), by Country, 2018 to 2033
Table 41: South Asia Market Volume (Units), by Application, 2018 to 2033
Table 42: South Asia Market Value (US$ Mn), by Application, 2018 to 2033
Table 43: South Asia Market Volume (Units), by Method, 2018 to 2033
Table 44: South Asia Market Value (US$ Mn), by Method, 2018 to 2033
Table 45: South Asia Market Volume (Units), by Technology, 2018 to 2033
Table 46: South Asia Market Value (US$ Mn), by Technology, 2018 to 2033
Table 47: South Asia Market Volume (Units), by End User, 2018 to 2033
Table 48: South Asia Market Value (US$ Mn), by End User, 2018 to 2033
Table 49: South Asia Market Volume (Units), by Country, 2018 to 2033
Table 50: South Asia Market Value (US$ Mn), by Country, 2018 to 2033
Table 51: Latin America Market Volume (Units), by Application, 2018 to 2033
Table 52: Latin America Market Value (US$ Mn), by Application, 2018 to 2033
Table 53: Latin America Market Volume (Units), by Method, 2018 to 2033
Table 54: Latin America Market Value (US$ Mn), by Method, 2018 to 2033
Table 55: Latin America Market Volume (Units), by Technology, 2018 to 2033
Table 56: Latin America Market Value (US$ Mn), by Technology, 2018 to 2033
Table 57: Latin America Market Volume (Units), by End User, 2018 to 2033
Table 58: Latin America Market Value (US$ Mn), by End User, 2018 to 2033
Table 59: Latin America Market Volume (Units), by Country, 2018 to 2033
Table 60: Latin America Market Value (US$ Mn), by Country, 2018 to 2033
Table 61: Middle East and Africa Market Volume (Units), by Application, 2018 to 2033
Table 62: Middle East and Africa Market Value (US$ Mn), by Application, 2018 to 2033
Table 63: Middle East and Africa Market Volume (Units), by Method, 2018 to 2033
Table 64: Middle East and Africa Market Value (US$ Mn), by Method, 2018 to 2033
Table 65: Middle East and Africa Market Volume (Units), by Technology, 2018 to 2033
Table 66: Middle East and Africa Market Value (US$ Mn), by Technology, 2018 to 2033
Table 67: Middle East and Africa Market Volume (Units), by End User, 2018 to 2033
Table 68: Middle East and Africa Market Value (US$ Mn), by End User, 2018 to 2033
Table 69: Middle East and Africa Market Volume (Units), by Country, 2018 to 2033
Table 70: Middle East and Africa Market Value (US$ Mn), by Country, 2018 to 2033
Table 71: Oceania Market Volume (Units), by Application, 2018 to 2033
Table 72: Oceania Market Value (US$ Mn), by Application, 2018 to 2033
Table 73: Oceania Market Volume (Units), by Method, 2018 to 2033
Table 74: Oceania Market Value (US$ Mn), by Method, 2018 to 2033
Table 75: Oceania Market Volume (Units), by Technology, 2018 to 2033
Table 76: Oceania Market Value (US$ Mn), by Technology, 2018 to 2033
Table 77: Oceania Market Volume (Units), by End User, 2018 to 2033
Table 78: Oceania Market Value (US$ Mn), by End User, 2018 to 2033
Table 79: Oceania Market Volume (Units), by Country, 2018 to 2033
Table 80: Oceania Market Value (US$ Mn), by Country, 2018 to 2033
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Fig 01: Global Market Volume (Units), Value (US$ Thousand) and Y-o-Y Growth, 2018 to 2033
Fig 02: Global Absolute $ Historical Market (2018-2022) and Absolute $ Opportunity (2023 to 2033), US$ Mn
Fig 03: Global Absolute Historical Volume Market (2018-2022) and Absolute Volume Opportunity (2023 to 2033), Units
Fig 04: Global Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Fig 05: Global Market Incremental $ Opportunity (US$ Thousand), 2023 to 2033
Fig 06: Global Market Share, By Application – 2023 to 2033
Fig 07: Global Market Y-o-Y Growth Projections, By Application – 2023 to 2033
Fig 08: Global Market Attractiveness Index, By Application – 2023 to 2033
Fig 09: Global Market Share, By Method – 2023 to 2033
Fig 10: Global Market Y-o-Y Growth Projections, By Method – 2023 to 2033
Fig 11: Global Market Attractiveness Index, By Method – 2023 to 2033
Fig 12: Global Market Share, By Technology – 2023 to 2033
Fig 13: Global Market Y-o-Y Growth Projections, By Technology – 2023 to 2033
Fig 14: Global Market Attractiveness Index, By Technology – 2023 to 2033
Fig 15: Global Market Share, By End User – 2023 to 2033
Fig 16: Global Market Y-o-Y Growth Projections, By End User – 2023 to 2033
Fig 17: Global Market Attractiveness Index, By End User – 2023 to 2033
Fig 18: Global Market Share, by Region – 2023 to 2033
Fig 19: Global Market Y-o-Y Growth Projections, by Region – 2023 to 2033
Fig 20: Global Market Attractiveness Index, by Region – 2023 to 2033
Fig 21: North America Market Value (US$ Thousand), Volume (Units) Forecast and Analysis, 2018 to 2033
Fig 22: Y-o-Y Growth Comparison of Market: North America Vs North America Countries Vs North America Average
Fig 23: North America Market Share, By Application – 2023 to 2033
Fig 24: North America Market Y-o-Y Growth Projections, By Application – 2023 to 2033
Fig 25: North America Market Attractiveness Index, By Application – 2023 to 2033
Fig 26: North America Market Share, By Method – 2023 to 2033
Fig 27: North America Market Y-o-Y Growth Projections, By Method – 2023 to 2033
Fig 28: North America Market Attractiveness Index, By Method – 2023 to 2033
Fig 29: North America Market Share, By Technology – 2023 to 2033
Fig 30: North America Market Y-o-Y Growth Projections, By Technology – 2023 to 2033
Fig 31: North America Market Attractiveness Index, By Technology – 2023 to 2033
Fig 32: North America Market Share, By End User – 2023 to 2033
Fig 33: North America Market Y-o-Y Growth Projections, By End User – 2023 to 2033
Fig 34: North America Market Attractiveness Index, By End User – 2023 to 2033
Fig 35: North America Market Share, By Country – 2023 to 2033
Fig 36: North America Market Y-o-Y Growth Projections, By Country – 2023 to 2033
Fig 37: North America Market Attractiveness Index, By Country – 2023 to 2033
Fig 38: Europe Market Value (US$ Thousand), Volume (Units) Forecast and Analysis, 2018 to 2033
Fig 39: Y-o-Y Growth Comparison of Market: Europe Vs Europe Countries Vs Europe Average
Fig 40: Europe Market Share, By Application – 2023 to 2033
Fig 41: Europe Market Y-o-Y Growth Projections, By Application – 2023 to 2033
Fig 42: Europe Market Attractiveness Index, By Application – 2023 to 2033
Fig 43: Europe Market Share, By Method – 2023 to 2033
Fig 44: Europe Market Y-o-Y Growth Projections, By Method – 2023 to 2033
Fig 45: Europe Market Attractiveness Index, By Method – 2023 to 2033
Fig 46: Europe Market Share, By Technology – 2023 to 2033
Fig 47: Europe Market Y-o-Y Growth Projections, By Technology – 2023 to 2033
Fig 48: Europe Market Attractiveness Index, By Technology – 2023 to 2033
Fig 49: Europe Market Share, By End User – 2023 to 2033
Fig 50: Europe Market Y-o-Y Growth Projections, By End User – 2023 to 2033
Fig 51: Europe Market Attractiveness Index, By End User – 2023 to 2033
Fig 52: Europe Market Share, By Country – 2023 to 2033
Fig 53: Europe Market Y-o-Y Growth Projections, By Country – 2023 to 2033
Fig 54: Europe Market Attractiveness Index, By Country – 2023 to 2033
Fig 55: East Asia Market Value (US$ Thousand), Volume (Units) Forecast and Analysis, 2018 to 2033
Fig 56: Y-o-Y Growth Comparison of Market: East Asia Vs East Asia Countries Vs East Asia Average
Fig 57: East Asia Market Share, By Application – 2023 to 2033
Fig 58: East Asia Market Y-o-Y Growth Projections, By Application – 2023 to 2033
Fig 59: East Asia Market Attractiveness Index, By Application – 2023 to 2033
Fig 60: East Asia Market Share, By Method – 2023 to 2033
Fig 61: East Asia Market Y-o-Y Growth Projections, By Method – 2023 to 2033
Fig 62: East Asia Market Attractiveness Index, By Method – 2023 to 2033
Fig 63: East Asia Market Share, By Technology – 2023 to 2033
Fig 64: East Asia Market Y-o-Y Growth Projections, By Technology – 2023 to 2033
Fig 65: East Asia Market Attractiveness Index, By Technology – 2023 to 2033
Fig 66: East Asia Market Share, By End User – 2023 to 2033
Fig 67: East Asia Market Y-o-Y Growth Projections, By End User – 2023 to 2033
Fig 68: East Asia Market Attractiveness Index, By End User – 2023 to 2033
Fig 69: East Asia Market Share, By Country – 2023 to 2033
Fig 70: East Asia Market Y-o-Y Growth Projections, By Country – 2023 to 2033
Fig 71: East Asia Market Attractiveness Index, By Country – 2023 to 2033
Fig 72: South Asia Market Value (US$ Thousand), Volume (Units) Forecast and Analysis, 2018 to 2033
Fig 73: Y-o-Y Growth Comparison of Market: South Asia Vs South Asia Countries Vs South Asia Average
Fig 74: South Asia Market Share, By Application – 2023 to 2033
Fig 75: South Asia Market Y-o-Y Growth Projections, By Application – 2023 to 2033
Fig 76: South Asia Market Attractiveness Index, By Application – 2023 to 2033
Fig 77: South Asia Market Share, By Method – 2023 to 2033
Fig 78: South Asia Market Y-o-Y Growth Projections, By Method – 2023 to 2033
Fig 79: South Asia Market Attractiveness Index, By Method – 2023 to 2033
Fig 80: South Asia Market Share, By Technology – 2023 to 2033
Fig 81: South Asia Market Y-o-Y Growth Projections, By Technology – 2023 to 2033
Fig 82: South Asia Market Attractiveness Index, By Technology – 2023 to 2033
Fig 83: South Asia Market Share, By End User – 2023 to 2033
Fig 84: South Asia Market Y-o-Y Growth Projections, By End User – 2023 to 2033
Fig 85: South Asia Market Attractiveness Index, By End User – 2023 to 2033
Fig 86: South Asia Market Share, By Country – 2023 to 2033
Fig 87: South Asia Market Y-o-Y Growth Projections, By Country – 2023 to 2033
Fig 88: South Asia Market Attractiveness Index, By Country – 2023 to 2033
Fig 89: Latin America Market Value (US$ Thousand), Volume (Units) Forecast and Analysis, 2018 to 2033
Fig 90: Y-o-Y Growth Comparison of Market: Latin America Vs Latin America Countries Vs Latin America Average
Fig 91: Latin America Market Share, By Application – 2023 to 2033
Fig 92: Latin America Market Y-o-Y Growth Projections, By Application – 2023 to 2033
Fig 93: Latin America Market Attractiveness Index, By Application – 2023 to 2033
Fig 94: Latin America Market Share, By Method – 2023 to 2033
Fig 95: Latin America Market Y-o-Y Growth Projections, By Method – 2023 to 2033
Fig 96: Latin America Market Attractiveness Index, By Method – 2023 to 2033
Fig 97: Latin America Market Share, By Technology – 2023 to 2033
Fig 98: Latin America Market Y-o-Y Growth Projections, By Technology – 2023 to 2033
Fig 99: Latin America Market Attractiveness Index, By Technology – 2023 to 2033
Fig 100: Latin America Market Share, By End User – 2023 to 2033
Fig 101: Latin America Market Y-o-Y Growth Projections, By End User – 2023 to 2033
Fig 102: Latin America Market Attractiveness Index, By End User – 2023 to 2033
Fig 103: Latin America Market Share, By Country – 2023 to 2033
Fig 104: Latin America Market Y-o-Y Growth Projections, By Country – 2023 to 2033
Fig 105: Latin America Market Attractiveness Index, By Country – 2023 to 2033
Fig 106: MEA Market Value (US$ Thousand), Volume (Units) Forecast and Analysis, 2018 to 2033
Fig 107: Y-o-Y Growth Comparison of Market: MEA Vs MEA Countries Vs MEA Average
Fig 108: MEA Market Share, By Application – 2023 to 2033
Fig 109: MEA Market Y-o-Y Growth Projections, By Application – 2023 to 2033
Fig 110: MEA Market Attractiveness Index, By Application – 2023 to 2033
Fig 111: MEA Market Share, By Method – 2023 to 2033
Fig 112: MEA Market Y-o-Y Growth Projections, By Method – 2023 to 2033
Fig 113: MEA Market Attractiveness Index, By Method – 2023 to 2033
Fig 114: MEA Market Share, By Technology – 2023 to 2033
Fig 115: MEA Market Y-o-Y Growth Projections, By Technology – 2023 to 2033
Fig 116: MEA Market Attractiveness Index, By Technology – 2023 to 2033
Fig 117: MEA Market Share, By End User – 2023 to 2033
Fig 118: MEA Market Y-o-Y Growth Projections, By End User – 2023 to 2033
Fig 119: MEA Market Attractiveness Index, By End User – 2023 to 2033
Fig 120: MEA Market Share, By Country – 2023 to 2033
Fig 121: MEA Market Y-o-Y Growth Projections, By Country – 2023 to 2033
Fig 122: MEA Market Attractiveness Index, By Country – 2023 to 2033
Fig 123: Oceania Market Value (US$ Thousand), Volume (Units) Forecast and Analysis, 2018 to 2033
Fig 124: Y-o-Y Growth Comparison of Market: Oceania Vs Oceania Countries Vs Oceania Average
Fig 125: Oceania Market Share, By Application – 2023 to 2033
Fig 126: Oceania Market Y-o-Y Growth Projections, By Application – 2023 to 2033
Fig 127: Oceania Market Attractiveness Index, By Application – 2023 to 2033
Fig 128: Oceania Market Share, By Method – 2023 to 2033
Fig 129: Oceania Market Y-o-Y Growth Projections, By Method – 2023 to 2033
Fig 130: Oceania Market Attractiveness Index, By Method – 2023 to 2033
Fig 131: Oceania Market Share, By Technology – 2023 to 2033
Fig 132: Oceania Market Y-o-Y Growth Projections, By Technology – 2023 to 2033
Fig 133: Oceania Market Attractiveness Index, By Technology – 2023 to 2033
Fig 134: Oceania Market Share, By End User – 2023 to 2033
Fig 135: Oceania Market Y-o-Y Growth Projections, By End User – 2023 to 2033
Fig 136: Oceania Market Attractiveness Index, By End User – 2023 to 2033
Fig 137: Oceania Market Share, By Country – 2023 to 2033
Fig 138: Oceania Market Y-o-Y Growth Projections, By Country – 2023 to 2033
Fig 139: Oceania Market Attractiveness Index, By Country – 2023 to 2033
Fig 140: United States Market share by Application, 2022
Fig 141: United States Market share by Method, 2022
Fig 142: United States Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 143: United States Market Share by End User, 2022
Fig 144: Canada Market share by Application, 2022
Fig 145: Canada Market share by Method, 2022
Fig 146: Canada Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 147: Canada Market Share by End User, 2022
Fig 148: Germany Market share by Application, 2022
Fig 149: Germany Market share by Method, 2022
Fig 150: Germany Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 151: Germany Market Share by End User, 2022
Fig 152: United Kingdom Market share by Application, 2022
Fig 153: United Kingdom Market share by Method, 2022
Fig 154: United Kingdom Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 155: United Kingdom Market Share by End User, 2022
Fig 156: France Market share by Application, 2022
Fig 157: France Market share by Method, 2022
Fig 158: France Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 159: France Market Share by End User, 2022
Fig 160: Russia Market share by Application, 2022
Fig 161: Russia Market share by Method, 2022
Fig 162: Russia Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 163: Russia Market Share by End User, 2022
Fig 164: Spain Market share by Application, 2022
Fig 165: Spain Market share by Method, 2022
Fig 166: Spain Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 167: Spain Market Share by End User, 2022
Fig 168: Italy Market share by Application, 2022
Fig 169: Italy Market share by Method, 2022
Fig 170: Italy Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 171: Italy Market Share by End User, 2022
Fig 172: China Market share by Application, 2022
Fig 173: China Market share by Method, 2022
Fig 174: China Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 175: China Market Share by End User, 2022
Fig 176: Japan Market share by Application, 2022
Fig 177: Japan Market share by Method, 2022
Fig 178: Japan Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 179: Japan Market Share by End User, 2022
Fig 180: South Korea Market share by Application, 2022
Fig 181: South Korea Market share by Method, 2022
Fig 182: South Korea Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 183: South Korea Market Share by End User, 2022
Fig 184: India Market share by Application, 2022
Fig 185: India Market share by Method, 2022
Fig 186: India Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 187: India Market Share by End User, 2022
Fig 188: Singapore Market share by Application, 2022
Fig 189: Singapore Market share by Method, 2022
Fig 190: Singapore Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 191: Singapore Market Share by End User, 2022
Fig 192: Indonesia Market share by Application, 2022
Fig 193: Indonesia Market share by Method, 2022
Fig 194: Indonesia Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 195: Indonesia Market Share by End User, 2022
Fig 196: Thailand Market share by Application, 2022
Fig 197: Thailand Market share by Method, 2022
Fig 198: Thailand Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 199: Thailand Market Share by End User, 2022
Fig 200: Brazil Market share by Application, 2022
Fig 201: Brazil Market share by Method, 2022
Fig 202: Brazil Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 203: Brazil Market Share by End User, 2022
Fig 204: Mexico Market share by Application, 2022
Fig 205: Mexico Market share by Method, 2022
Fig 206: Mexico Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 207: Mexico Market Share by End User, 2022
Fig 208: Turkey Market share by Application, 2022
Fig 209: Turkey Market share by Method, 2022
Fig 210: Turkey Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 211: Turkey Market Share by End User, 2022
Fig 212: GCC Countries Market share by Application, 2022
Fig 213: GCC Countries Market share by Method, 2022
Fig 214: GCC Countries Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 215: GCC Countries Market Share by End User, 2022
Fig 216: South Africa Market share by Application, 2022
Fig 217: South Africa Market share by Method, 2022
Fig 218: South Africa Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 219: South Africa Market Share by End User, 2022
Fig 220: Australia Market share by Application, 2022
Fig 221: Australia Market share by Method, 2022
Fig 222: Australia Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 223: Australia Market Share by End User, 2022
Fig 224: New Zealand Market share by Application, 2022
Fig 225: New Zealand Market share by Method, 2022
Fig 226: New Zealand Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 227: New Zealand Market Share by End User, 2022
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the current market value for transfection technologies?
The transfection technologies market is valued at US$ 1.10 billion in 2023.
What is the growth rate of the transfection technologies market?
Global demand for transfection technologies is expected to increase at a CAGR of 7.5% from 2023 to 2033.
How big will be the market by 2033?
Revenue from the sales of transfection technologies is projected to reach US$ 2.27 billion by 2033.
Which region leads the global market for transfection technologies?
North America holds a dominating position in the global transfection technologies market.
Who are the key companies in the global market for transfection technologies?
[18:18] Vaishnavi Mendhi Thermo Fisher Scientific, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, and Life Technologies Corporation are some of the key market players.
Transfection Technologies Market